Single-Step Scalable-Throughput Molecular Screening for Huntington Disease
Author(s) -
Clara R L Teo,
Wen Wang,
Hai Yang Law,
Caroline Lee,
Samuel S. Chong
Publication year - 2008
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2007.096503
Subject(s) - amplicon , trinucleotide repeat expansion , huntingtin , huntington's disease , biology , genetics , penetrance , allele , cutoff , microbiology and biotechnology , polymerase chain reaction , gene , pathology , medicine , disease , mutant , phenotype , physics , quantum mechanics
Huntington disease (HD) is a fatal autosomal dominant neurodegenerative disorder caused by an unstable expansion of the CAG trinucleotide repeat in exon 1 of the HTT (huntingtin) gene and typically has an adult onset. Molecular diagnosis and screening for HD currently involve separate amplification and detection steps.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom